SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-23-047463
Filing Date
2023-09-11
Accepted
2023-09-11 16:06:34
Documents
15
Period of Report
2023-10-09

Document Format Files

Seq Description Document Type Size
1 DEF 14A ktra-20230911.htm   iXBRL DEF 14A 653858
2 GRAPHIC img139668541_0.jpg GRAPHIC 543033
3 GRAPHIC img139668541_1.jpg GRAPHIC 629445
  Complete submission text file 0000950170-23-047463.txt   3861573

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ktra-20230911_lab.xml EX-101.LAB 3164
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ktra-20230911.xsd EX-101.SCH 2461
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ktra-20230911_pre.xml EX-101.PRE 2764
8 EXTRACTED XBRL INSTANCE DOCUMENT ktra-20230911_htm.xml XML 1303
Mailing Address 9920 PACIFIC HEIGHTS BLVD, SUITE 150 SAN DIEGO CA 92121
Business Address 9920 PACIFIC HEIGHTS BLVD, SUITE 150 SAN DIEGO CA 92121 (858) 350-4364
Kintara Therapeutics, Inc. (Filer) CIK: 0001498382 (see all company filings)

IRS No.: 990360497 | State of Incorp.: NV | Fiscal Year End: 0630
Type: DEF 14A | Act: 34 | File No.: 001-37823 | Film No.: 231247789
SIC: 2834 Pharmaceutical Preparations